The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant. This information will help to improve the understanding of the needs for travel health strategies and interventions to provide healthy and safe travel to HSCT patients. The findings of this survey will also be used to develop travel health related interventions for patients living with cancer as well.
Study Type
OBSERVATIONAL
Enrollment
519
The intervention is a self-administered questionnaire that is voluntarily completed by the subject. This questionnaire has been previously validated and demonstrated to be reproducible in English speaking travelers. The final version of the survey questionnaire consists of 49 questions.Patients who never traveled after HSCT will answer only eighteen questions related to their medical and HSCT history in addition to their demographics.
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
prevalence of international travel
of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT
Time frame: 2 years
international travel was during a high-risk specific period
Proportion of patients traveling to destinations that are at high risk areas for infections
Time frame: 2 years
patients that sought pre-travel health advice
among those who traveled to high risk areas for infections
Time frame: 2 years
travelers that becomes ill and required medical attention
during or after return from international travel.
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.